High dose chemotherapy and autologous blood stem cell support in women with breast carcinoma and isolated supraclavicular lymph node metastases

Cancer

Volumn 88, Issue 4, 2000, Pages 790-795

  Abraham, Rick ^a   Nagy, Tracy ^a   Goss, Paul E ^a   Crump, Michael ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

High dose chemotherapy; Metastatic breast carcinoma; Stem cell transplantation; Supraclavicular lymph nodes

Indexed keywords

ANTHRACYCLINE; CARBOPLATIN; CYCLOPHOSPHAMIDE; MITOXANTRONE; TAMOXIFEN; TAXANE DERIVATIVE;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LYMPH NODE METASTASIS; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARBOPLATIN; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; MITOXANTRONE; NECK; RETROSPECTIVE STUDIES; SURVIVAL RATE; TAMOXIFEN;

EID: 0034651797     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000215)88:4<790::AID-CNCR9>3.0.CO;2-M     Document Type: Article

References (29)

1. Fisher BJ, Perera FE, Cooke AL, Opeitum A, Venkatesan V, Dar AR, et al. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: patterns of recurrence. Int J Radiat Oncol Biol Phys 1997;38:541-50.
2. Halverson KJ, Perez CA, Kuske RR, Garcia DM, Simpson JR, Fineberg B. Locoregional recurrence of breast cancer: a retrospective comparison of irradiation alone versus irradiation and systemic therapy. Am J Clin Oncol 1992;15:93-101.
3. Schwaibold F, Fowble B, Solin LJ, Schultz DJ, Goodman RL. The results of radiation therapy for isolated local regional recurrence after mastectomy. Int J Radiat Oncol Biol Phys 1991;21:299-310.
4. Kiricuta I, Willner J, Kolbl O, Bohndorf W. The prognostic significance of the supraclavicular lymph node metastases in breast cancer patients. Int J Radiat Oncol Biol Phys 1993; 28:387-93.
5. Willner J, Kiricuta IC, Kolbl O. Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis. Int J Radiat Oncol Biol Phys 1997;37:853-63.
6. Janjan NA, McNeese MD, Buzdar AU. Loco-regional recurrent breast cancer treated with radiation or a combination of radiation and chemotherapy. Int J Radiat Oncol Biol Phys 1985;11(Suppl 1):152-3.
7. Toonkel LM, Fix I, Jacobson LH, Wallach CB. The significance of local recurrence of carcinoma of the breast. Int J Radiat Oncol Biol Phys 1983;9:33-9.
8. Bedwinek JM, Fineberg B, Lee J, Ocwieza M. Analysis of failures following local treatment of isolated local-regional recurrence of breast cancer. Int J Radiat Oncol Biol Phys 1981;7:581-5.
9. Borner M, Bacchi M, Goldhirsch A, Greiner R, Harder F, Castiglione M, et al. First isolated local-regional recurrence following mastectomy for breast cancer: results of a phase III multi-center study comparing systemic treatment with observation after excision and radiation. J Clin Oncol 1994; 12:2071-7.
10. Deutsch M, Parsons JA, Mittal BB. Radiation therapy for local-regional recurrent breast cancer. Int J Radiat Oncol Biol Phys 1986;12:2061-5.
11. Baker WJ, Vukelja SJ, Lee N, Perry JJ. High-dose cyclophosphamide, etoposide and carboplatin with autologous bone marrow support for metastatic breast cancer: long-term results. Bone Marrow Transplant 1998;21:775-8.
12. Ayash LJ, Wheeler C, Fairclough D, Schwartz G, Reich E, Warren D, et al. Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer. J Clin Oncol 1995;13:2043-9.
13. Cagnoni PJ, Shpall EJ, Bearman SI, Ross M, Jones RB. High-dose chemotherapy with AHPCS for the treatment of breast cancer. The University of Colorado results. Bone Marrow Transplant 1996;17:526.
14. Weaver CH, West WH, Schwartzberg LS, Alberico T, Leff R, Greco FA, et al. Induction, mobilization of peripheral blood stem cells (PBSC), high-dose chemotherapy and PBSC infusion in patients with untreated stage IV breast cancer: outcomes by intent to treat analyses. Bone Marrow Transplant 1997;19:661-70.
15. Patnaik A, Mackinnon J, Goss PE, Nagy T, Stewart K, Keating A, et al. Phase I-II trial of cyclophosphamide (C), mitoxantrone (M), and escalated doses of carboplatin (Car) supported by peripheral blood stem cells in women with metastatic breast cancer. Proc Am Soc Clin Oncol 1997;16: 111a.
16. Kaplan EL, Meiet P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
17. Girouard C, Crump M. High-dose chemotherapy with stem cell support for metastatic breast cancer. Curr Oncol 1996; 3:40-5.
18. Antman KH, Rowlings PA, Vaughan WP, Pelz CJ, Fay JW, Fields KK, et al. High-dose chemotherapy with autologous hematopoietic stem cell support for breast cancer in North America. J Clin Oncol 1997;15:1870-9.
19. Rowlings PA, Williams SF, Antman KH, Fields KK, Fay JW, Reed E, et al. Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem-cell transplantation for metastatic breast cancer. JAMA 1999;282:1335-43.
20. Halverson KJ, Perez CA, Kuske RR, Garcia DM, Simpson JR, Fineberg B. Survival following locoregional recurrence of breast cancer: univariate and multivariate analysis. Int J Radiat Oncol Biol Phys 1992;23:285-91.
21. Patanaphan V, Salazar OM, Poussin-Rosillo H. Prognosticators in recurrent breast cancer: a fifteen year experience with irradiation. Cancer 1984;54:228-34.
22. Magno L, Bignardi M, Micheletti E, Bardelli D, Plebani F. Analysis of prognostic factors in patients with isolated chest wall recurrence of breast cancer. Cancer 1987;60:240-4.
23. Kamby C, Sengelov L. Pattern of dissemination and survival following isolated locoregional recurrence of breast cancer. A prospective study with more than 10 years of follow up. Breast Cancer Res Treat 1997;45:181-92.
24. Carter CL, Allen C, Henson D. Relation of tumor size, lymph node status and survival in 24,740 breast cancer cases. Cancer 1989;63:181-7.
25. Pergolizzia S, Settineri N, Russi E, Maisano R, Adamo V, Santacaterina A, et al. Supraclavicular lymph node metastases (SLM) from breast cancer as only site of distant disease: has radiotherapy any role? Anticancer Res 1997;17: 2303-8.
26. Shah AB, Hartsell WF, Ghalie R, Kaizer H. Patterns of failure following bone marrow transplantation for metastatic breast cancer: the role of consolidative radiotherapy. Int J Radiat Oncol Biol Phys 1995;32:1433-8.
27. Bezwoda WR, Seymour L, Dansey RD. High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial. J Clin Oncol 1995;13:2483-9.
28. Stadmauer EA, O'Neill A, Goldstein LJ, Crilley P, Mangan KF, Ingle JN, et al. Phase III randomized trial of high-dose chemotherapy (HDC) shows no difference in overall survival or severe toxicity compared to maintenance chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) for women with metastatic breast cancer who are responding to conventional induction chemotherapy: the "Philadelphia" Intergroup Study (PBT-1). Proc Am Soc Clin Oncol 1999;18:1a.
29. Crump M, Gluck S, Pritchard K, Shepherd L, Pater J. High-dose chemotherapy with autologous hematopoietic stemcell support for breast cancer in North America [letter]. J Clin Oncol 1998;16:800-1.